Cargando…
Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
I describe how we identified the need to block the luteinizing hormone (LH) surge when trying to control the processes of luteinization and ovulation within the clinic. The first step, in fact, was using ovarian ultrasound evaluation of follicular development in the natural cycle (published in 1979)...
Autor principal: | Fleming, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201284/ https://www.ncbi.nlm.nih.gov/pubmed/37223758 http://dx.doi.org/10.1016/j.xfre.2022.11.007 |
Ejemplares similares
-
Gonadotropin-releasing hormone: incredible 50 years
por: Paulson, Richard J., et al.
Publicado: (2023) -
The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
por: Lambalk, Cornelis B.
Publicado: (2023) -
Early preclinical work with gonadotropin-releasing hormone analogues
por: Gordon, Keith
Publicado: (2023) -
Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
por: Chwalisz, Kristof
Publicado: (2023) -
Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigm
por: Filicori, Marco
Publicado: (2023)